International Journal of Head and Neck Surgery

Register      Login

VOLUME 6 , ISSUE 4 ( October-December, 2015 ) > List of Articles


Diagnostic and Management Challenges in Mikulicz Syndrome

Abhinandan Bhattacharjee, S Uddin, Rudra Prakash, Aakansha Rathor, Sanchita Kalita

Citation Information : Bhattacharjee A, Uddin S, Prakash R, Rathor A, Kalita S. Diagnostic and Management Challenges in Mikulicz Syndrome. Int J Head Neck Surg 2015; 6 (4):139-145.

DOI: 10.5005/jp-journals-10001-1243

Published Online: 01-03-2017

Copyright Statement:  Copyright © 2015; The Author(s).


How to cite this article

Bhattacharjee A, Uddin S, Prakash R, Rathor A, Kalita S. Diagnostic and Management Challenges in Mikulicz Syndrome. Int J Head Neck Surg 2015;6(4): 139-145.

PDF Share
  1. A clinicopathologic study of Mikulicz's disease. Am J Pathol 1953 May-Jun;29(3):471-503.
  2. The probable systemic nature of Mikulicz's disease and its relation to Sjögren syndrome. N Engl J Med 1954 Jul;251(1):5-10.
  3. Mickulicz's syndrome – a report of ten cases. Am J Dis Child 1927 Sep;34(3):327-346.
  4. The development of malignant lymphoma in the course of Sjögren's syndrome. Am J Med 1964;36:529-540.
  5. Clinical and pathological differences between Mickulicz's disease and Sjogren's syndrome. Rheumatology 2005 Feb;44(2):227-234.
  6. Distribution and immunophenotype of the inflammatory cell population in benign lymphoepithelial lesion (MD). Hum Pathol 1988 Aug;19(8):932-941.
  7. Apoptosis and Sjögren syndrome seminars in arthritis and rheumatism. Semin Arthritis Rheum 2003 Aug;33(1):49-65.
  8. Apoptosis and estrogen deficiency in primary Sjögren syndrome. Curr Opin Rheumatol 2004 Nov;16(5):552-556.
  9. Sjögren's syndrome: a clinical pathological and serological study of sixty-two cases. Medicine (Baltimore) 1965 May;44(3):187-231.
  10. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesta. Mayo Clin Proc 2001 Jun;76(6):593-599.
  11. Treatment of oral dryness related complaints in Sjögren's syndrome. Ann Rheum Dis 1999;58(8):465-473.
  12. Salivary mucins in oral mucosal defence. Gen Pharmacol 1996 Jul; 27(5):761-771.
  13. Sjögren's syndrome. Yonsei Med J 2003 Dec 30;44(6):947-954.
  14. Role of salivary IgA in the pathogenesis of Sjögren syndrome. Clin Immunol 2002 Jul;104(1):49-57.
  15. Primary Sjögren syndrome in paediatric age: a multicentre survey. Eur J Pediatr 2003 Oct;162(10):661-665.
  16. Hearing loss in the Sjögren syndrome. Ann Intern Med 1997 Mar;126(6):450-453.
  17. Characterisation of a cross reactive idiotype in Sjögren's syndrome. Scand J Rheum 1986;561 (Suppl):83-88.
  18. Cutaneous manifestation of primary Sjögren's syndrome. A reflection of vasculitis and association with anti-Ro (SSA) antibodies. J Invest Dermatol 1983 May;80(5):386-391.
  19. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004 Mar;83(2):96-106.
  20. Subcutaneous nodular amyloidosis in Sjögren's syndrome. Scand J Rheumatol 1993;22(5):250-251.
  21. Primary anetoderm. Cutis 1998 Aug;62(2):101-103.
  22. Urticarial vasculitis. Int Angiol 1995 Jun;14(2):166-174.
  23. Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus. J Am Acad Dermatol 1991 Sep;25(3):557-560.
  24. Liver involvement in primary Sjögren's syndrome. Br J Rheumatol 1994 Aug;33(8):745-748.
  25. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004 Sep;83(5):280-291.
  26. Neuropsychiatric dysfunction in primary Sjögren's syndrome. Ann Intern Med 1985 Sep;103(3):344-350.
  27. Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications. J Neuroimmunol 2004 May;150(1-2):107-115.
  28. Increased risk of lymphoma in primary in sicca syndrome. Ann Intern Med 1978;89(6):888-892.
  29. Renal disease with Sjögren's syndrome. In: Talal N, Moutsopoulos HM, Kassan SS, editors. Sjogren's syndrome: clinical and immunological aspects. Berlin: Springer Verlag; 1987. p. 96.
  30. Mixed cryoglobulinemia and monoclonal rheumatic factor cross-reactive idiotypes as predicting factors for development of lymphoma in primary Sjogren's syndrome. Arthritis Rheum 1996 May;39(5):767-772.
  31. Sjogren's syndrome. Otolaryngol Clin North Am 1999 Oct;32(5):843-860.
  32. Serological profiles in subgroups of patients with Sjogren's syndrome. Scand J Rheumatol 1986;61 (Suppl):89-92.
  33. Prevalence of ANCA in a large inception cohort of patients with connective tissue disorder. Ann Intern Med 1997 Jun 1;126(11):866-873.
  34. Antiphospholipid antibodies and HLA association in primary Sjogren's syndrome. Ann Rheum Dis 1992 Apr;51(4):495-498.
  35. Parotid sialography for diagnosing Sjögren syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002 Jul;94(1):131-137.
  36. Salivary and serum β2-microglobulin and γ-glutamyl-transferase in patients with primary Sjögren syndrome patients and Sjögren syndrome secondary to systemic lupus erythematosus. Clinica Chimica Acta 2003 Sept;334(1-2):225-231.
  37. Diagnosis of Mikulicz-Sjögren syndrome using biopsy of the minor salivary glands. Vojnosanitetski Preglad 2002 Nov-Dec;59(6):615-620.
  38. Role of parotid biopsy in the diagnosis of paediatric Sjögren syndrome. Arch Otolaryngol Head Neck Surg 2002 Nov;128(11):1279-1281.
  39. Benign lymphoepithelial lesion (Mikulicz's disease) of the salivary gland: an ultrastructural study. Hum Pathol 1979 Jan;10(1):99-104.
  40. Pathological features of lymphoid proliferations of the salivary glands: lymphoepithelial sialadenitis versus low-grade B-cell lymphoma of the malt type. Ann Otol Rhinol Laryngol 2000 Dec;109(12 Pt 1):1170-1175.
  41. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004 Sep;83(5):280-291.
  42. Methotrexate in primary Sjögren's syndrome. Clin Exp Rheumatol 1996 Sep-Oct;14(5):555-558.
  43. A case of Mikulicz's disease complicated with interstitial nephritis successfully treated by high-dose corticosteroid. Mod Rheumatol 2006;16(3):176-182.
  44. Malignant change in lymphoepithelial lesion of the parotid gland – report of 3 cases. Chi J Oncol 1986 Jan;8(1):76-77.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.